Cencora (COR)
Largest Insider Buys in Sector
COR Stock Price History Chart
COR Stock Performance
About Cencora
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and …
Insider Activity of Cencora
Over the last 12 months, insiders at Cencora have bought $109,290 and sold $2.53B worth of Cencora stock.
On average, over the past 5 years, insiders at Cencora have bought $109,290 and sold $1.55B worth of stock each year.
Highest buying activity among insiders over the last 12 months: DURCAN DERMOT MARK (director) — $218,580.
The last purchase of 500 shares for transaction amount of $109,290 was made by DURCAN DERMOT MARK (director) on 2024‑05‑24.
List of Insider Buy and Sell Transactions, Cencora
| 2024-12-03 | Sale | SVP & Chief Accounting Officer | 1,816 0.0009% | $250.41 | $454,754 | -7.12% | ||
| 2024-11-25 | Sale | Executive Chairman | 50,000 0.0251% | $243.97 | $12.2M | -0.93% | ||
| 2024-11-19 | Sale | Executive Chairman | 21,509 0.0107% | $242.16 | $5.21M | +1.18% | ||
| 2024-10-22 | Sale | Executive Chairman | 21,509 0.0104% | $235.80 | $5.07M | +3.54% | ||
| 2024-09-17 | Sale | Chairman, President & CEO | 21,509 0.0107% | $241.01 | $5.18M | -0.15% | ||
| 2024-08-20 | Sale | Chairman, President & CEO | 10,754 0.0053% | $239.13 | $2.57M | -1.04% | ||
| 2024-08-06 | Sale | Executive Vice President | 1,473 0.0007% | $242.69 | $357,482 | -1.16% | ||
| 2024-08-01 | Sale | 10 percent owner | 4.44M 2.1959% | $240.56 | $1.07B | -3.03% | ||
| 2024-07-16 | Sale | Chairman, President & CEO | 10,755 0.0049% | $222.12 | $2.39M | +5.08% | ||
| 2024-06-18 | Sale | Chairman, President & CEO | 10,754 0.0052% | $235.76 | $2.54M | -0.64% | ||
| 2024-05-31 | Sale | Executive Vice President | 1,874 0.0009% | $223.86 | $419,506 | +3.73% | ||
| 2024-05-29 | Sale | Executive Vice President | 27,093 0.012% | $216.07 | $5.85M | +7.27% | ||
| 2024-05-24 | director | 500 0.0002% | $218.58 | $109,290 | +7.33% | |||
| 2024-05-22 | Sale | 10 percent owner | 1.86M 0.8227% | $215.12 | $400M | +8.32% | ||
| 2024-05-21 | Sale | Chairman, President & CEO | 10,755 0.0049% | $221.30 | $2.38M | +8.14% | ||
| 2024-04-16 | Sale | Chairman, President & CEO | 10,754 0.0053% | $237.48 | $2.55M | -1.32% | ||
| 2024-04-15 | Sale | Executive Vice President & COO | 57,564 0.0278% | $235.09 | $13.53M | +0.40% | ||
| 2024-03-19 | Sale | Chairman, President & CEO | 10,755 0.0053% | $240.21 | $2.58M | -2.78% | ||
| 2024-03-18 | Sale | Executive Vice President | 9,644 0.0047% | $238.12 | $2.3M | -1.53% | ||
| 2024-03-18 | Sale | Executive Vice President | 6,977 0.0034% | $238.12 | $1.66M | -1.53% |
Insider Historical Profitability
| DURCAN DERMOT MARK | director | 21876 0.0113% | $227.69 | 1 | 0 | |
| Szurek Paul E. | President & CEO | 242347 0.1254% | $227.69 | 3 | 13 | +8.95% |
| COLEMAN JAMES H | Sr. VP, Business Development | 200397 0.1037% | $227.69 | 1 | 0 | <0.0001% |
| STOLL ROGER G PHD | Chief Executive Officer | 100000 0.0517% | $227.69 | 7 | 0 | <0.0001% |
| DRAKE PETER F | director | 50000 0.0259% | $227.69 | 1 | 0 | <0.0001% |